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Grillet et al., page 328
Nonsyndromic sensorineural hearing loss (NSHL) is a
common form of deafness. It is typically caused by impaired
sensory hair cell function within the cochlea, the hearing
organof the ear. Although aging is thought to be responsible
for a progressive form of hearing loss, other forms have
underlying genetic causes, as is the case for autosomal-
recessive NSHL (ARNSHL). Numerous genetic loci have
been linked toARNSHLandare referred toasDFNB1 through
DFNB76. Though mutations in numerous genes have been
associated with the DFNB loci, only three genes have previ-
ously been associatedwith the progressive form of ARNSHL;
all ofwhich encodeproteins that localize to the cochlearhair
cells. Here, Grillet and colleagues use SNP mapping and
genetic sequencing to identify amutation in Loxhd1 as caus-
ative for the ARNSHL observed in a genetically modiﬁed
mouse line called samba. They ﬁnd this protein to consist
exclusively of PLAT domains and to be expressed in cochlear
hair cells. They then take their research into humans and
identify a previously uncharacterized ARNSHL locus,
DFNB77, mapping to 18q12-q21 and containing LOXHD1.
The authors further identifymutations in LOXHD1 as being
causative for a DFNB77 family presenting with progressive
hearing loss. Together, these results help elucidate a role for
PLAT domains and shed insight into progressive ARNSHL.
Cerebral Folate Transport Deficiency
Steinfeld et al., page 354
Folate deﬁciency affects a variety of cellular functions and
can be caused by nutritional inadequacies or by disruption
of folate transport and metabolism. Many of the proteins
and pathways involved in folate uptake and processing
have been well studied, and disruption of these processes
has been reported to cause generalized folate deﬁciency.
In contrast, Robert Steinfeld and his colleagues are
studying three patients with developmental regression,
movement disturbances, epilepsy, and leukodystrophy
due to a brain-speciﬁc folate deﬁciency. An analysis of
the cerebral spinal ﬂuid in the patients reveals very low
folate metabolite concentrations, but normal levels are
observed in plasma and erythrocytes. After screening the
patients for mutations in the genes involved in folate
transport, the authors identify mutations in FOLR1, theThe Americangene that encodes folate receptor alpha. Functional studies
with patient cells demonstrate that the mutations signiﬁ-
cantly decrease folate binding and that this function can
be rescued by the introduction of wild-type FOLR1. Impor-
tantly, each of the patients is treated with folinic acid
therapy and shows signiﬁcant clinical improvements.
Generalized Disequilibrium Test
Chen et al., page 364
As the wealth of genotype information collected from
disease data sets has grown, there is an ongoing need for
methods that will allow efﬁcient and proper analysis of
these data. In the world of association analysis, studies are
usually designed to use either population-based data, in
which affected cases are compared to unaffected controls,
or family-based data, in which between-family and
within-family differences are exploited for the identiﬁca-
tion of genetic associations. Well-established advantages
of family-based designs are that they allow for the use of
families that have already been collected for linkage studies
and they are also robust to population stratiﬁcation. Here,
Chen and colleagues add to the arsenal of family-based
data-analysis tools with the development of their general-
ized disequilibrium test (GDT). Some highlights of the
important capabilities of the GDT are that the method is
able to use all of the data from a variety of different relative
pairs, it can incorporate covariates, and its calculations are
reliable even when handling information from a small
number of families of unequal size. In comparisons to ﬁve
other established methods on data simulating a variety of
affectation status and missing data situations, the authors
evaluate the power advantages and universality of the
GDT. Chen et al. then use the methods to look for variants
associatedwith type 1diabetes in a large family data set con-
sisting of affected sibling pairs, discordant sibling pairs,
other discordant relative pairs, and missing parental data.
The GDT efﬁciently conﬁrms previously reported associa-
tions at a greater signiﬁcance level than the other methods
andalso identiﬁespotentially interesting sex-related effects.
Allele-Specific Epigenetics of Asthma
Verlaan et al., page 377
Allelic expression refers to the potential of a variation on
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that same allele. This allelic variation of cis-regulation
can be due to X chromosome inactivation, imprinting,
or polymorphism. Recent studies have associated allelic
variation with common disease phenotypes, including
asthma. Asthma is a chronic condition in which the
airways of the lungs, or bronchi, become inﬂamed and
cause constriction. Though there are environmental
factors that may trigger an asthma attack, there is also
a genetic component to this disease. In this issue,
Verlaan and colleagues analyze the 17q12-q21 locus
to uncover mechanisms of transcriptional control of
asthma-related genes, because SNPs within this locus
have been associated with risk for asthma, type 1 dia-
betes, primary biliary cirrhosis, and Crohn disease. Indi-
vidual differences in allelic expression make up one
reason that associated alterations in genes may affect
a certain disease phenotype in one person but not in
another. This group identiﬁes a haplotype exerting al-
lelic expression of at least three asthma-related genes.
Additional functional studies show that cis-regulation
of chromatin organization and binding properties of
CTCF, a DNA insulator protein, are associated with this
haplotype. They further associate SNPs within this cis-
regulatory haplotype with risk of asthma in three inde-
pendent cohorts. Together, these data provide insight
into the mechanism of transcriptional control of genes
likely to be involved in asthma and several autoimmune
disorders.304 The American Journal of Human Genetics 85, 303–304, SeptemPositive Modifier of Spinal Muscular Atrophy
Prior et al., page 408
The two SMN genes on 5q13 have an interesting collabora-
tive relationship that can affect whether or not a person
develops spinal muscular atrophy (SMA). The two genes,
SMN1 and SMN2, are almost completely identical, except
that SMN2 contains a variant that affects splicing and leads
to high levels of transcript that lacks exon 7 and to corre-
sponding low levels of full-length message. Because of this,
when a mutation affects SMN1, SMN2 is, in general, unable
to compensate for the loss of SMN1, and SMA is the result.
There have been, though, recent ﬁndings that have demon-
strated that patients who have a higher copy number of
SMN2 have a less-severe disease and, in some cases, are
completely unaffected. This is presumably due to the addi-
tive effect of having several SMN2 copies producing low
levels of functional full-length transcript. Here, Prior and
colleagues describe three SMA patients who have a shared
genotype-phenotype relationship, which adds a bit of com-
plexity to the story. Each of the cases has a milder form of
SMA than expected by their SMN2 copy number. Sequence
analysis of SMN2 in these patients identiﬁes a single base
pair change that is shown to alter splicing and increase the
inclusionofexon7.Thisﬁndingunderscores the importance
of understanding the effects of each variant in these genes
and highlights the possible beneﬁts to be achieved by
increasing full-length SMN2 expression in SMA patients.ber 11, 2009
